Log In
Print this Print this

RORgamma agonist

  Manage Alerts
Collapse Summary General Information
Company Lycera Corp.
DescriptionRAR-related orphan receptor C (RORC; RORgamma) agonist
Molecular Target RAR-related orphan receptor C (RORC) (RORgamma)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
PartnerCelgene Corp.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
Get a free BioCentury trial today